← FDA Drug Approvals (Drugs@FDA)

NAROPIN

NDA · New Drug Application · Sponsor: FRESENIUS KABI USA · Approved 1996-09-24

Drug application

FDA Application #

NDA020533

Application type

New Drug Application

Brand name

NAROPIN

Generic name

ROPIVACAINE HYDROCHLORIDE

Active ingredients

ROPIVACAINE HYDROCHLORIDE

Dosage form

SOLUTION

Route

INJECTION

Marketing status

Prescription

Sponsor

FRESENIUS KABI USA

Manufacturer

Fresenius Kabi USA, LLC

First approval

1996-09-24

Source

Authoritative

Drugs@FDA application overview

Machine

JSON-LD · Markdown